CytoSorbents (NASDAQ:CTSO) reported its Q4 earnings results on Tuesday, March 8, 2022 at 04:15 PM.
Here's what investors need to know about the announcement.
Earnings
CytoSorbents missed estimated earnings by 61.54%, reporting an EPS of $-0.21 versus an estimate of $-0.13.
Revenue was down $1.17 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.03 which was followed by a 2.62% increase in the share price the next day.
Here's a look at CytoSorbents's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.12 | -0.04 | -0.03 | -0.04 |
| EPS Actual | -0.15 | -0.11 | -0.10 | -0.01 |
| Revenue Estimate | 11.02M | 12.27M | 11.50M | 10.95M |
| Revenue Actual | 9.76M | 12.02M | 10.60M | 11.96M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
